SG3 Management, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$5,414,545
+136.4%
119,500
+264.3%
0.78%
+401.3%
Q3 2022$2,290,376
+90.9%
32,800
+124.7%
0.16%
+358.8%
Q1 2022$1,200,000
-93.1%
14,600
-87.7%
0.03%
-90.4%
Q4 2021$17,456,000
-49.1%
119,000
-38.7%
0.35%
-66.0%
Q3 2021$34,321,000
+786.6%
194,000
+758.4%
1.04%
+972.2%
Q1 2021$3,871,000
-86.3%
22,600
-82.4%
0.10%
-81.9%
Q4 2020$28,223,000
+1316.1%
128,500
+970.8%
0.54%
+635.6%
Q3 2020$1,993,000
+132.8%
12,000
+60.0%
0.07%
+23.7%
Q2 2020$856,000
+102.4%
7,500
+36.4%
0.06%
+3.5%
Q1 2020$423,0005,5000.06%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$688,784,00067.42%
Avoro Capital Advisors LLC 4,535,000$996,067,00017.15%
Darwin Global Management, Ltd. 260,876$57,299,00015.99%
Boxer Capital, LLC 1,765,560$387,788,00012.46%
Perceptive Advisors 3,693,516$811,244,0008.71%
Consonance Capital Management LP 330,000$72,481,0006.77%
EcoR1 Capital, LLC 464,298$101,978,0005.48%
Fairmount Funds Management LLC 60,500$13,288,0004.75%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,400$14,804,0004.04%
RTW INVESTMENTS, LP 1,054,364$231,581,0003.88%
View complete list of MIRATI THERAPEUTICS INC shareholders